An Extension Clinical Study of BCD-148 for the Treatment of Patients With PNH Previously Treated in Clinical Study No. BCD-148-2/NOCTURN

PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 13, 2020

Primary Completion Date

November 2, 2022

Study Completion Date

November 2, 2022

Conditions
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Interventions
BIOLOGICAL

eculizumab

Intravenous infusion of BCD-148 every 2 weeks

Trial Locations (11)

Unknown

"Territorial State Budgetary Healthcare Institution Territorial Clinical Hospital", Barnaul

"State Autonomous Healthcare Institution S.V. Belyaev Kuzbass Regional Clinical Hospital", Kemerovo

"Federal State Budgetary Institution of Science Kirov Research Institute of Hematology and Blood Transfusion of the Federal Medical and Biological Agency", Kirov

"Moscow State Budgetary Healthcare Institution S.P. Botkin Municipal Clinical Hospital of the Moscow Healthcare Department", Moscow

"Federal State Budgetary Educational Institution of Higher Education Rostov State Medical University of the Ministry of Health of the Russian Federation", Rostov-on-Don

"Federal State Budgetary Educational Institution of Higher Education Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Health of the Russian Federation", Saint Petersburg

"Federal State Budgetary Educational Institution of Higher Education I.I. Mechnikov North-Western State Medical University of the Ministry of Health of the Russian Federation", Saint Petersburg

"Federal State Budgetary Educational Institution of Higher Education Samara State Medical University of the Ministry of Health of the Russian Federation", Samara

"State Institution Komi Republican Cancer Clinic", Syktyvkar

"Federal State Budgetary Educational Institution of Higher Education Bashkir State Medical University of the Ministry of Health of the Russian Federation", Ufa

"State Autonomous Healthcare Institution of the Sverdlovsk Region Sverdlovsk Regional Clinical Hospital No. 1", Yekaterinburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biocad

INDUSTRY

NCT06987864 - An Extension Clinical Study of BCD-148 for the Treatment of Patients With PNH Previously Treated in Clinical Study No. BCD-148-2/NOCTURN | Biotech Hunter | Biotech Hunter